BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hepatitis
,
Adipose tissue
,
Pharmacogenetics
,
Doxorubicin
,
rs2300478
,
ZBTB7A
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
GCNT2;jsessionid=87A7A77BCAAA0F7024E1A0695EBC8A15
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Prostate gland
Kidney medulla
Kidney cortex
Lung
Trachea
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Bilateral congenital membranous cataracts due to Glucosaminyl (N-Acetyl) Transferase 2 (GCNT2) mutat…
Loss of GCNT2/I-branched glycans enhances melanoma growth and survival.
Deletion at the GCNT2 Locus Causes Autosomal Recessive Congenital Cataracts.
Downregulation of miR-199a/b-5p is associated with GCNT2 induction upon epithelial-mesenchymal trans…
Aberrant methylation of GCNT2 is tightly related to lymph node metastasis of primary CRC.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for GCNT2;jsessionid=87A7A77BCAAA0F7024E1A0695EBC8A15
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ